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Abstract—Background: A complicated form of recessive hereditary spastic paraplegias (HSPs) with thin corpus callosum
(TCC) was first described in Japan, and most of the Japanese families showed linkage to chromosome 15q13–15. A
recessive HSP locus (SPG11) has also been mapped to chromosome 15q13–15 in Italian and North American families with
and without TCC, and it overlaps the region identified in the Japanese families. Objective: To study clinically and
genetically 12 Italian families with HSP and TCC. Methods: The authors investigated 18 affected and 30 healthy
individuals from 12 unrelated Italian families with recessive HSP-TCC. Clinical, neurophysiologic, and neuroradiologic
studies were undertaken. All patients were negative for SPG7 mutations. Genetic linkage analyses were carried out with
polymorphic DNA markers on 15q13–15. Results: Five families were consistent with linkage, thus defining a 19.8-cM
region between markers D15S1007 and D15S978, encompassing the SPG11 interval. In one consanguineous family,
linkage could be firmly excluded, confirming genetic heterogeneity. Two families appeared not linked to the region, but
this could not be firmly proved because of the small family size. The remaining four families were uninformative for
linkage purposes. Conclusion: HSP-TCC is common in Italy. The phenotype is fairly homogeneous and is associated with
impaired cognition. There are at least two loci for HSP-TCC, one of which is on chromosome 15q13–15.
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Autosomal recessive hereditary spastic paraplegia
with thin corpus callosum (HSP-TCC) is character-
ized by normal motor development, slowly progres-
sive spastic paraparesis, mental retardation, and
extremely thin corpus callosum.1,2 Additional symp-
toms include muscular atrophy, extrapyramidal
symptoms, and cerebellar ataxia, and epileptic sei-
zures may occur, often late in the disease progres-
sion.3 HSP-TCC was described in Japan and is
considered essentially a Japanese subtype of HSP.4
In American and European countries, HSP-TCC ap-
pears to be rare: only six white families with HSP-
TCC have been reported thus far, including one each
from the United States, Italy, Spain, and Portugal
and two from Brazil.5-7 It is uncertain whether the
frequency of HSP-TCC is underrated in Western
countries.
In one North American and two Italian recessive
HSP families, of which two had TCC, an SPG11 lo-
cus has been mapped to the long arm of chromosome
15.5 Normal corpus callosum in one of these three
families suggested phenotypic variability. The
SPG11 region spans 10.2 cM and overlaps by 4.3 cM
the locus responsible for Andermann’s syndrome
(AS, [MIM #218000]), a neurologic condition with
peripheral neuropathy and agenesis of the corpus
callosum.8,9 More recently, linkage to chromosome
15q13–15 has been reported in 10 of 13 Japanese
families with HSP-TCC.10 The HSP-TCC interval
identified spans 19.9 cM and overlaps by 4.6 cM the
SPG11 region but not the AS locus (figure 1).9
We report clinical and genetic studies of 12 Italian
families with HSP-TCC.
Methods. Clinical study. Twelve Italian families were studied.
Clinical features of affected patients are summarized here. For
identification codes for families and individuals, refer to figure 2.
Family OS. The proband is a 13-year-old boy (H27) born to
healthy first-degree cousins. His elder sister (H30) is healthy. He
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achieved autonomous walking at age 16 months. Learning prob-
lems were reported during his first school years. At age 10 years,
he started walking on tiptoe. Neurologic examination showed py-
ramidal tract signs in his lower limbs. Since then, his motor dis-
ability has slowly progressed, and he is now unable to walk
unaided. Brain MRI showed TCC and diffuse periventricular
white matter changes. A biopsy of deltoid muscle at age 12 years
showed normal oxidative phosphorylation histochemically and bio-
chemically. Nerve sensory conduction velocities, EEG, somatosen-
sory evoked potentials (SSEPs), visual evoked potentials (VEPs),
electroretinogram, and brainstem auditory evoked responses
(BAERs) were normal. Nerve motor conduction velocity of the
deep peroneal nerve was in the lower range (41 m/s) with reduced
compound motor action potential (CMAP) amplitude (5.4 mV).
Motor evoked potentials (MEPs) were markedly delayed for lower
limbs and moderately delayed for upper limbs.
Family DKD. A 29-year-old woman (H82) born to healthy,
nonconsanguineous parents was aged 13 years when she first had
stiffness while walking. At that time she was attending school
regularly and went on to obtain a high school diploma without
difficulty. After age 17 years, her walking worsened, and she
became unable to walk unassisted at approximately age 20 years.
At that age, insidious mental deterioration ensued. She is now
wheelchair-bound, severely dysarthric, and mentally impaired.
Neurologic examination showed severe spasticity—more evident
in her lower limbs—hand muscle amyotrophy, extremely brisk
tendon reflexes, and bilateral Babinski sign. MRI showed striking
TCC and white matter changes (figure 3). Her 24-year-old sister
(H83) presented with hand tremor at age 17 years and received a
diagnosis of essential tremor. At that age, a brain MRI was simi-
lar to that of her older sister. In the following years, walking
difficulties, pyramidal tract involvement in the lower limbs, and
progressive mental deterioration became evident, although to a
lesser degree than in her sister’s case.
Family NPE. In this family, two siblings are affected,
whereas their unrelated parents are healthy. The first proband
(H73), now aged 17 years, had normal motor and intellectual
development until age 13 years, when motor disability first be-
came apparent. At age 15 years, neurologic examination showed
hyperreflexia in her lower limbs, extensor plantar reflexes, and
increased muscle tone but normal strength. Cognitive status was
normal. MRI showed TCC and periventricular white matter
changes. She is still ambulant, but mild mental deterioration is
now evident. Her 16-year-old brother (H70) began to experience
walking difficulties at age 15 years after a normal motor and
cognitive development. Neurologic examination showed normal in-
tellectual abilities, increased muscle tone, hyperreflexia, extensor
plantar reflexes, and normal strength. His MRI showed the same
abnormalities as his sister. Nerve sensory and motor conduction
velocities in upper and lower limbs were normal. Both patients
had normal EEG, VEPs, electroretinogram, and BAERs. SSEPs
with stimulation of upper limbs were normal, whereas stimulation
of the lower limbs showed delayed responses. MEPs were delayed
in the lower limbs only.
Family F1. Two patients, a 33-year-old man (H21) and a 28-
year-old woman (H19), were born to healthy first-degree cousins.
Motor development was normal. At age 12 years, difficulties in
running and frequent falls were noted, and leg “stiffness” was
reported. These symptoms slowly worsened until autonomous
walking became impossible at age 19 years for the boy and at age
20 years for his sister. A recent neurologic examination showed
severe bilateral lower limb spasticity, brisk tendon reflexes and
Babinski sign, and dysarthric speech in both patients. Upper
limbs are unaffected. Both patients attended secondary school
with poor results. Neuropsychological examination showed poor
performances on the Wechsler Adult Intelligence Scale (WAIS; IQ
 75). A brain MRI of H21 at age 32 years showed moderate
cortical atrophy along with TCC in the brother, whereas the sister
had only TCC at age 27 years. MRI was normal in the patients’
mother. Two other sisters (H18 and H20) are normal.
Family PS. A 19-year-old man (H77) was born to healthy
unrelated parents. He showed mild learning disabilities in pri-
mary school. After age 17 years, he presented progressive gait
disturbances, urinary urgency, and cognitive impairment. The lat-
ter consists of emotional lability and childlike attitude along with
difficulties in concentration. Neurologic examination revealed
mild spastic paraparesis and hyper-reactive tendon reflexes and
Babinski sign. Brisk reflexes were also noted in the upper limbs.
MRI showed marked TCC and periventricular white matter
changes. His 20-year-old brother (H80) is normal.
Family SM. A 27-year-old woman (H5) was born an only child
of healthy unrelated parents. Learning disability was clearly evi-
dent at age 10 years and subsequently worsened to moderate
dementia. Walking became difficult after age 12 years and impossi-
ble at age 17 years. MRI at that time showed TCC. She is now
wheelchair-bound, severely dysarthric, and requires continuous as-
sistance. Neurologic examination showed severe pyramidal tract in-
volvement (more marked in her lower limbs), dysarthria, mild
Figure 1. Schematic representation of the genetic map of
part of human chromosome 15 showing the Andermann
region as determined in reference 9 (flanking markers,
D15S1040 and ACTC); the SPG11 region as determined in
reference 5 (flanking markers, D15S1007 and D15S1012);
the Japanese hereditary spastic paraplegia with thin cor-
pus callosum (HSP-TCC) linked region as determined in
reference 10 (flanking markers, D15S971 and D15S117);
the ALS5 region as determined in reference 19 (flanking
markers, D15S146 and D15S123); and the HSP-TCC re-
gion as determined in our families (flanking markers,
D15S1007 and D15S978). Markers with one asterisk (*)
are those genotyped in all 12 families, and markers with
two asterisks (**) are those genotyped in only six families
(see Results section and lane B, figure 2). Marker location
and intermarker distances are taken from the Marshfield
chromosome 15 genetic map and confirmed on the physi-
cal map of the University of California at Santa Cruz’s
Human Genome Working Draft.
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cerebellar signs, and dysphagia. At age 24 years, MRI showed un-
equivocal signs of disease progression: marked frontal and parietal
cortical atrophy, white matter changes in periventricular areas, and
further thinning of corpus callosum (see figure 3).
Family RA. A 26-year-old woman (H13) born to unrelated
healthy parents began to have difficulties walking at approxi-
mately age 19 years. Gait disturbances have progressed insidi-
ously along with mild mental changes, mainly represented by
childlike behavior. Neurologic examination was consistent with
marked spastic paraparesis. MRI showed TCC and frontal cortex
atrophy. Two younger sisters (H14 and H15) aged 24 and 20 years
are normal.
Family B1. The proband (H32) is now aged 17 years. His
parents are healthy and unrelated. He achieved autonomous
walking at age 16 months, and mental development was report-
edly normal. He began to have learning disabilities during pri-
mary school. At age 11 years, he experienced walking difficulties.
At age 14 years, a neurologic examination showed spasticity in his
lower limbs. A brain MRI at that age showed TCC and periven-
tricular frontal and occipital white matter changes. SSEPs with
stimulation of the lower limbs were delayed. Nerve motor conduc-
tion velocity in his lower limbs was in the lower range (43 m/s)
with reduced CMAP amplitude (3.2 mV). MEPs were markedly
delayed in his lower limbs and moderately delayed in his upper
limbs. At present, he requires support while walking and has
moderate mental deficiency. An older sister (H34) is normal.
Family B2. A 6-year-old boy (H24) born to healthy unrelated
parents was able to sit at age 7 months but had delayed psy-
chomotor development. At age 4 years, he walked tiptoeing and
could barely speak. Neurologic examination showed increased ten-
don reflexes and bilateral Babinski sign. MRI showed subtotal
“agenesis” of corpus callosum and periventricular hyperintensities
on T2-weighted images. MEPs were delayed in his lower limbs.
Two older siblings (H25 and H26) are healthy.
Family PA. In this family, two siblings (H62 and H63) were
born to healthy, unrelated parents. Mental and motor develop-
ment was normal. The elder sibling, a 44-year-old man (H62), was
examined for stiffness while walking and mental deterioration at
age 16 years. Neuropsychological examination showed poor perfor-
mances on the WAIS test (IQ  60). Twenty years after disease
onset, he was wheelchair-bound. His 31-year-old sister (H63)
started walking on tiptoe at age 19 years. Subsequently, she de-
veloped progressive mental deterioration. Independent walking
was impossible at age 35 years. Neurologic examination showed
dysarthria, dysphagia, spastic paraplegia with weakness and dis-
tal wasting of the upper limbs, reduced vibration sense in the
lower limbs, and urinary incontinence in both siblings, and claw
foot in Patient H62. MRI showed TCC, cortical atrophy, and cere-
bral white matter changes in both siblings. Median nerve electro-
physiologic studies performed in Patient H63 showed a motor
conduction velocity in the lower range (52 m/s) and a reduced
sensory velocity (38 m/s).
Family SP. Two siblings aged 20 and 13 years (H28 and H29)
were born to unrelated healthy parents. A third brother (H30) is
normal. Patient (H28) had normal motor milestones, but learning
problems were evident during her first school years. After age 15
years, she had progressive gait disturbances. On the latest neuro-
logic examination, she was still able to walk independently. Mild
weakness, distal wasting, and increased tendon reflexes in lower
limbs and extensor plantar response were found. WAIS IQ was 78.
Her younger brother (H29) has shown progressive walking disabil-
ity beginning at age 12 years. Neurologic examination showed
spastic gait, mild weakness in his lower limbs, increased tendon
reflexes and extensor plantar response, and claw foot. Mild cogni-
tive impairment is also present (IQ  89). Nerve motor conduction
velocity of peroneal nerve is reduced (38 m/s). SSEPs are normal,
whereas MEPs are delayed in both patients. MRI revealed
Figure 2. Pedigrees of the 12 Italian families with autosomal recessive spastic paraparesis and thin corpus callosum
(HSP-TCC). (Lane A) Families uninformative or only partially informative for linkage purposes. (Lane B) Families OS,
DKD, NPE, PE, and PA are consistent with linkage to the 15q13–15 chromosomal region, whereas in Family F1 linkage
with the whole region has been definitely excluded. Black symbols denote individuals affected by HSP-TCC. Deceased
members are marked with a diagonal bar, and individuals who were clinically examined and blood sampled are coded
with the letter “H,” followed by a number.
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changes of periventricular white matter in both siblings and of
TCC in the elder.
Family PE. In this family, two affected siblings (H60 and
H61) were born to healthy unrelated parents. The 18-year-old boy
(H60) achieved autonomous walking at age 2 years and had de-
layed speech development. At age 13 years, he presented learning
problems and difficulties in writing. One year later, he had pro-
gressive gait disturbance. Neurologic examination showed mild
spastic gait with increased tendon reflexes in the upper and lower
limbs and lower limb weakness, claw foot, and writing tremor.
WAIS IQ is 66. MEPs were delayed. His younger sister has mild
spastic gait and mild cognitive impairment. MRI showed TCC and
white matter changes in both siblings.
All probands underwent biochemical screening tests based on
the extensive list of differential diagnoses proposed by the HSP
Working Group.11
Genetic analysis. DNA was extracted from peripheral blood
leukocytes using standard protocols. In all affected patients, we
had previously ruled out SPG7 mutations by direct sequencing.12
All available individuals from the 12 families were genotyped for
four microsatellite markers spanning the region on chromosome
15q13–15 (D15S971, D15S1042, D15S968, and D15S659; see fig-
ure 1). Microsatellite markers were PCR amplified from genomic
DNA using fluorescein-labeled primers and electrophoresed on a
capillary 3100 DNA Sequencer (Applied Biosystems, Foster City,
CA). DNA fragment size analysis was performed semiautomati-
cally using the Genescan and Genotyper software (Applied Biosys-
tems) to determine genotypes. Haplotypes were manually
constructed, and phase was assigned based on the minimum num-
ber of recombinants. Pair-wise lod scores were obtained using the
FASTLINK version of the MLINK program, under the assumption
of equal male-female recombination rate, autosomal recessive in-
heritance, full penetrance, gene frequency of 0.001, and equal
allele frequencies for each marker.13 Multipoint lod scores were
generated using the SIMWALK2 program.14 Linkage homogeneity
was tested in nine families with the HOMOG program using the
multipoint lod scores at every 0.5 cM between markers D15S971
and D15S659.15 Six families were genotyped for four additional
microsatellite markers (D15S1007, D15S1012, D15S978, and
D15S117; see figure 1 and the Results section). Marker location
and genetic distances were based on the chromosome 15 genetic
map of the Center for Medical Genetics, Marshfield Medical Re-
search Foundation. Marker order was also confirmed on the phys-
ical map of the University of California at Santa Cruz’s Human
Genome Working Draft.
Results. Clinical study. This study includes 18 pa-
tients (9 men and 9 women), belonging to 12 families, with
a fairly homogeneous clinical presentation that meets the
clinical and radiologic criteria for the complicated form of
HSP-TCC first reported in Japan.2,10 The diagnosis was
further supported by negative results of laboratory investi-
gations, including serum creatine kinase, very long fatty
acids, amino acids, urinary organic acids, lysosomal en-
zymes in leukocytes, and CSF isoelectrofocusing. Five
cases were sporadic, whereas in seven families, there were
two affected siblings, consistent with autosomal recessive
transmission. Consanguinity was present in two families.
The median age at first examination was 17 years (range,
4 to 21 years). The median age at onset for motor symp-
toms was 13 years (range, 4 to 20 years). Motor symptoms
consisted mainly of walking difficulties and a tendency to
walk on the toes. All patients had bilateral pyramidal tract
involvement that started in the lower limbs, where it re-
mained more evident after subsequent diffusion to the up-
per limbs over the years. Worsening of the motor signs,
with relatively rapid course, was found in all patients on
successive examinations. In at least eight patients, inde-
Figure 3. Brain MRI T1-weighted
images on the sagittal plane in Pa-
tient H5 from Family SM show thin-
ning of the corpus callosum (A) and
progression of atrophy of the corpus
callosum at follow-up scan obtained
10 years later (B). Brain MRI of Pa-
tient H82 from Family DKD shows
severe thinning of body and genu of
the corpus callosum on sagittal T1-
weighted images (C) and hyperinten-
sity of periventricular white matter
on axial T2-weighted images (D).
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pendent walking was impossible after 8 or 9 years of dis-
ease progression. Late dysarthria was a constant feature
in patients with severe advanced disease. The frequency of
additional signs, including sphincter disturbances such as
urinary urgency and frequency, seemed to increase with
disease duration. Neurophysiologic studies showed delayed
central MEPs and signs of motor peripheral neuropathy.
All patients had mild to moderate cognitive impairment,
often consisting of attention problems and “fatuous” behav-
ior suggesting frontal lobe dysfunction. Cognitive impair-
ment generally followed the onset of motor signs, but early
learning disability preceding spastic paraparesis was also
reported. Brain MRI in all patients showed TCC ranging
from severe to extreme. In at least one patient, successive
MRI examinations suggested progressive atrophy. Periven-
tricular white matter changes were found almost con-
stantly (15/18 patients, 83%). Frontal cortical atrophy
seemed to be a late feature.
Linkage analysis. Linkage to the 15q13–15 chromo-
somal region was first tested with four microsatellite
markers (D15S971, D15S1042, D15S968, and D15S659) in
48 individuals from the 12 families (18 affected members
and 30 unaffected relatives). In three families (PS, SM,
and B1), two-point lod scores were entirely uninformative
at all recombination fractions for the four markers ana-
lyzed (range, 0.0 to 0.12). Moreover, haplotype construction
did not allow either to exclude or to confirm linkage with
the HSP-TCC region (data not shown). These families were
excluded from further analysis. Linkage homogeneity was
tested in the remaining nine families with the HOMOG
program using the multipoint lod scores at every 0.5 cM
between markers D15S971 and D15S659. The maximum
likelihood was obtained for the condition of linkage and
heterogeneity, with a maximum alpha value of 0.55.
Multipoint lod scores were positive across the entire
region for families DKD, NPE, PE, PA, and OS (range,
0.65 to 1.32); the conditional probability in favor of linkage
was 0.96 for Family OS and 0.87 for the other four fami-
lies. Conversely, families F1, RA, and SP generated nega-
tive lod scores across the whole interval (range, 9.45 to
0.89), and the conditional probability in favor of linkage
was equal or close to zero. Family B2 generated multipoint
lod score values that ranged from not informative to mildly
negative across the region. For this family, the conditional
probability in favor of linkage was 0.68 but with broad
support limits (0.00 to 0.94).
The five families with a high probability in favor of
linkage (DKD, NPE, PE, PA, and OS) were genotyped for
four additional microsatellite markers (D15S1007,
D15S1012, D15S978, D15S117; see figure 1) to better de-
fine the genetic extension of the HSP-TCC interval. These
markers were also genotyped in consanguineous Family
F1, in which linkage could be firmly excluded (multipoint
lod score values were 2.00 across the entire interval
tested), to ensure exclusion of linkage to the whole region
and confirm genetic heterogeneity.
Haplotype construction. Five families (OS, DKD, NPE,
PA, and PE) were consistent with linkage to the SPG11
region. Figure 2 shows the pedigrees of these families and
haplotypes for the eight markers spanning the candidate
interval on chromosome 15q13–15. In consanguineous
Family OS, the affected individual (H27) was homozygous
across the region, whereas his unaffected sister (H30)
showed different haplotypes. In the other nonconsanguine-
ous families, affected siblings shared identical haplotypes
within the 15q13–15 region. The maximum cumulative
two-point lod score for these five families was 3.35 for
marker D15S659 at theta  0.00. Cumulative multipoint
linkage analysis is shown in figure 4. Affected individuals
from each family showed different haplotypes, which ex-
cludes a common founder effect and suggests independent
mutational events. In these five families, the upper extent
Figure 4. Multipoint lod scores between the disease and markers spanning the hereditary spastic paraplegia with thin
corpus callosum (HSP-TCC) region. The black line indicates the cumulative multipoint analysis for families OS, DKD,
NPE, PA, and PE, and the dashed line refers to Family F1 (see Results).
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of the region is determined by recombinations detected in
subjects H27 (Family OS) and H82 (Family DKD) between
markers D15S1007 and D15S971, whereas the lower ex-
tent of the region is defined in individual H70 (Family
NPE) between markers D15S659 and D15S978 (see figure
2). This identifies a 19.8-cM region encompassing the
SPG11 interval reported by Martínez Murillo et al. and the
AS region5,9 and partially overlapping the minimal chromo-
somal region as defined in Japanese HSP-TCC families10
(see figure 1). In consanguineous Family F1, linkage to the
entire 15q13–15 region could be excluded. The two affected
individuals (H21 and H19) showed different haplotypes
across the whole interval, whereas one affected sibling
(H19) shared identical haplotypes with one of his healthy
sisters (H20). Negative two-point lod scores were obtained
at all theta values for all eight microsatellite markers.
This was confirmed by multipoint linkage analysis, which
generated lod scores 2.00 for the entire candidate inter-
val (see figure 4). The clinical picture of Family F1 is not
distinguishable from that of the other families consistent
with linkage to the 15q13–15 region, which corroborates
genetic heterogeneity.
Discussion. We report on the clinical and genetic
investigations of 12 Italian families with HSP-TCC,
for a total of 18 affected individuals—the largest
group of patients investigated outside Japan. Clini-
cal features closely matched those reported in Japa-
nese patients, suggesting that HSP-TCC is more
widespread than previously believed.10 Such a high
frequency has never been reported in other large
series of autosomal recessive HSP, raising the possi-
bility that HSP-TCC is underrated in Western
countries.6,16-18
The phenotype of HSP-TCC consists of pyramidal
tract involvement, initially confined to lower limbs
with subsequent diffusion to upper limbs, and pro-
gressive cognitive impairment. This allows for a rel-
atively easy clinical diagnosis. Motor dysfunction
worsens progressively, and independent walking be-
comes impossible at approximately age 20 years, on
average. Thinning—possibly progressive—of the cor-
pus callosum is the neuroradiologically distinctive
feature of this syndrome and further confirms the
fairly homogeneous clinical presentation. Periven-
tricular white matter changes and late cortical atro-
phy are additional, almost constant, features, which
may be used in the differential diagnosis.
A maximum two-point lod score of 3.35 for marker
D15S659 (at theta  0.00) is consistent with linkage
to the chromosome 15q13–15 region for five families.
Affected individuals from different families did not
share a common haplotype, which excludes a founder
effect and suggests frequent independent mutational
events in the Italian population (see figure 2) with a
relative high frequency of carriers. Our results also
show that HSP-TCC is genetically heterogeneous. In
at least one case (Family F1), we excluded linkage to
the whole region on chromosome 15. Our findings
are in agreement with those reported by the Japa-
nese study, in which only 10 of 13 HSP-TCC families
were linked to chromosome 15q13–15.10 It seems
that HSP-TCC cannot be unequivocally identified
with the SPG11 locus. Pending identification of the
disease gene(s), patients without evidence of linkage
must be considered as genetically different, although
a distinct SPG locus number cannot yet be assigned.
Four families were uninformative for linkage pur-
poses, and two families produced ambiguous results.
Until the mutated gene is identified, these families
cannot be considered either consistent with linkage
or unlinked to SPG11. This is a frequent problem in
autosomal recessive disorders because of the small
size of families, which are often composed of only one
affected individual with or without unaffected
siblings.
The region on chromosome 15q13–15 identified in
our families is broad and encompasses entirely the
described SPG11 locus5 and the AS locus.8 Although
a single gene—with variable expression—accounting
for these neurologic conditions could be postulated,
recent refinement of the AS locus does not support
this hypothesis (see figure 1), suggesting that the
causative genes are distinct.9 Another neurologic
condition affecting the motor pathways, an autoso-
mal recessive form of ALS (ALS5), has been mapped
to a 5.9-cM interval within the HSP-TCC region (see
figure 1).19 ALS5 families have onset in early adult-
hood and involvement of upper and lower motor neu-
rons and mild mental retardation. Although the
ALS5 region does not overlap the reported SPG11
region, the possibility that HSP-TCC and ALS5 may
represent allelic disorders of the same gene cannot
formally be excluded.5 The identification of different
mutations in the ALS2 gene in juvenile primary lat-
eral sclerosis (which often mimics HSP)20 and early-
onset recessive ALS21 is a recent example of two
clinically distinguished neurologic disorders of the
motor pathways that later proved to be allelic.
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